Texas Permanent School Fund Embecta Corp. Transaction History

Texas Permanent School Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$10.13 - $14.6 $70,818 - $102,068	-6,991 Reduced 13.96%	43,096 $538,000
Q1 2024 May 03, 2024	BUY	$12.35 - $19.33 $9,978 - $15,618	808 Added 1.64%	50,087 $664,000
Q4 2023 Feb 08, 2024	BUY	$12.87 - $19.09 $11,325 - $16,799	880 Added 1.82%	49,279 $932,000
Q3 2023 Nov 09, 2023	SELL	$15.0 - $22.17 $30,705 - $45,381	-2,047 Reduced 4.06%	48,399 $728,000
Q2 2023 Aug 07, 2023	SELL	$21.6 - $30.69 $18,532 - $26,332	-858 Reduced 1.67%	50,446 $1.09 Million
Q1 2023 May 01, 2023	BUY	$23.07 - $32.77 $286,575 - $407,068	12,422 Added 31.95%	51,304 $1.44 Million
Q4 2022 Feb 07, 2023	SELL	$25.29 - $35.48 $68,004 - $95,405	-2,689 Reduced 6.47%	38,882 $983,000
Q3 2022 Oct 25, 2022	SELL	$24.0 - $33.42 $4,896 - $6,817	-204 Reduced 0.49%	41,571 $1.2 Million
Q2 2022 Aug 08, 2022	BUY	$24.78 - $33.36 $1.04 Million - $1.39 Million	41,775 New	41,775 $1.06 Million

403

51.2M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $846M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

Stay updated on Texas Permanent School Fund with notifications on news.